tirzepatide compounding ruling Important Notice: Update See if you qualify. Lilly asks to join lawsuit

Approach with caution and only under qualified medical supervision

doi:10.1016/S0140-6736(07)60279-7

Alhadeff, PhD, senior study author After reviewing this study, Shruti Pandiri, MD, assistant professor of medicine in the Division of Endocrinology with the Center for Weight Loss & Metabolic Health at Hackensack University Medical Center in New Jersey, told MNT the findings of this study have the potential to lead to the development of GLP-1-based obesity drugs with improved tolerability

Surgical Body Contouring Options for Post-GLP-1 Patients Surgical intervention remains the most effective solution for significant excess skin after GLP-1 weight loss